Medical technology company MED-EL announced Thursday that the US Food and Drug Administration has approved expanding the use ...

An FDA study in two groups of children shows that MED-EL cochlear implants are safe and effective for children seven-71 months old with bilateral SNHL who cannot hear well enough with hearing aids.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Ray Cathey is on a journey from silence to new sounds. Cathey's hearing took a pounding when he was an air rescue paramedic ...

Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to ...

For Katelyn and Justin Hargrave, hearing a diagnosis for their four-week-old daughter Kennedy was just the start of a long ...

The US Food and Drug Administration (FDA) has approved an expanded indication for MED-EL’s SYNCHRONY cochlea implants in ...

P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" ...

USA: A new cohort study presents a reliable and scalable method to evaluate auditory nerve function and peripheral neural plasticity in vivo across the lifespan. The results emphasize that early ...

The biotech specialises in epilepsy monitoring and prevention, but saw its shares slump on debut. The company says it is ...

Cochlear is starting to make use of the AI capabilities in its Amazon Connect contact centre platform, automating its ...